vision loss

MSD Snatches Eyebiotech Ltd for $3bn Dominates Vision Loss Market

May 30, 2024

BIOT

💰 US pharma giant MSD acquires Eyebiotech Ltd for up to $3bn, gaining their clinical pipeline of vision loss candidates. 👁️‍🗨️🩺 Unanimously approved by EyeBio Board.

MSD Snatches Eyebiotech Ltd for $3bn Dominates Vision Loss Market

Process development

Concordia’s $5M Boost for Eco-Friendly Innovation!

Process development

Revolutionary Raman Spectroscopy Calibration Without Bioreactors!

Upstream

Revolutionary Bioreactor Makes Cancer Therapies a Breeze!

Automation and digitalization

Unlocking Bioprocessing: How Ontologies Boost Efficiency!

Upstream

Unlocking MSC Production: The Power of Media Choice!

Upstream

Revolutionary Fermentation Tech Promises Higher Profits!

vision loss

MSD Snatches Eyebiotech Ltd for $3bn Dominates Vision Loss Market

most recent

Process development

Concordia’s $5M Boost for Eco-Friendly Innovation!

Process development

Revolutionary Raman Spectroscopy Calibration Without Bioreactors!

Upstream

Revolutionary Bioreactor Makes Cancer Therapies a Breeze!

Automation and digitalization

Unlocking Bioprocessing: How Ontologies Boost Efficiency!

Upstream

Unlocking MSC Production: The Power of Media Choice!

Upstream

Revolutionary Fermentation Tech Promises Higher Profits!